Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2

The choice of oral anticoagulant (OAC) for patients with atrial fibrillation (AF) may be influenced by individual clinical features or by patterns of risk factors and comorbidities. We reviewed analyses of subgroups of patients from trials of vitamin K antagonists vs. non-vitamin K oral anticoagulan...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur Heart J
Huvudupphovsmän: Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan L., Hohnloser, Stefan H., Hylek, Elaine M., Kirchhof, Paulus, Lane, Deirdre A., Verheugt, Freek W.A., Veltkamp, Roland, Lip, Gregory Y.H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Reviews
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837363/
https://ncbi.nlm.nih.gov/pubmed/26848150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw069
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk